200 related articles for article (PubMed ID: 31359329)
21. Effect of anticholinergic use for the treatment of overactive bladder on cognitive function in postmenopausal women.
Geller EJ; Crane AK; Wells EC; Robinson BL; Jannelli ML; Khandelwal CM; Connolly A; Parnell BA; Matthews CA; Dumond JB; Busby-Whitehead J
Clin Drug Investig; 2012 Oct; 32(10):697-705. PubMed ID: 22873491
[TBL] [Abstract][Full Text] [Related]
22. Relationship Between Overactive Bladder and Bone Fracture Risk in Female Patients.
Mori S; Matsuo T; Honda H; Araki K; Mitsunari K; Ohba K; Imamura R
In Vivo; 2024; 38(4):2031-2040. PubMed ID: 38936892
[TBL] [Abstract][Full Text] [Related]
23. Limitations of anticholinergic cycling in patients with overactive bladder (OAB) with urinary incontinence (UI): results from the CONsequences of Treatment Refractory Overactive bLadder (CONTROL) study.
Chancellor MB; Yehoshua A; Waweru C; Globe D; Cheng IN; Campbell KL; Joshi M; Pulicharam R
Int Urol Nephrol; 2016 Jul; 48(7):1029-36. PubMed ID: 27032397
[TBL] [Abstract][Full Text] [Related]
24. Increased risk of dementia among patients with overactive bladder treated with an anticholinergic medication compared to a beta-3 agonist: a population-based cohort study.
Welk B; McArthur E
BJU Int; 2020 Jul; 126(1):183-190. PubMed ID: 32167223
[TBL] [Abstract][Full Text] [Related]
25. Drugs with anticholinergic effects and cognitive impairment, falls and all-cause mortality in older adults: A systematic review and meta-analysis.
Ruxton K; Woodman RJ; Mangoni AA
Br J Clin Pharmacol; 2015 Aug; 80(2):209-20. PubMed ID: 25735839
[TBL] [Abstract][Full Text] [Related]
26. Treatments for overactive bladder: focus on pharmacotherapy.
Geoffrion R;
J Obstet Gynaecol Can; 2012 Nov; 34(11):1092-1101. PubMed ID: 23231848
[TBL] [Abstract][Full Text] [Related]
27. The Differential Risk of Mortality Among Users of Overactive Bladder Anticholinergic Medications and β3 Agonists.
Welk B
Eur Urol Focus; 2023 Jan; 9(1):168-171. PubMed ID: 35987891
[TBL] [Abstract][Full Text] [Related]
28. Consistency between anticholinergic burden scales in the elderly with fractures.
Valladales-Restrepo LF; Duran-Lengua M; Castro-Osorio EE; Machado-Alba JE
PLoS One; 2020; 15(2):e0228532. PubMed ID: 32092055
[TBL] [Abstract][Full Text] [Related]
29. Inequities in Filled Overactive Bladder Medication Prescriptions in the US.
Luchristt D; Bretschneider CE; Kenton K; Simon M; Brown O
JAMA Netw Open; 2023 May; 6(5):e2315074. PubMed ID: 37223899
[TBL] [Abstract][Full Text] [Related]
30. A high anticholinergic burden is associated with a history of falls in the previous year in middle-aged women: findings from the Aberdeen Prospective Osteoporosis Screening Study.
Ablett AD; Wood AD; Barr R; Guillot J; Black AJ; Macdonald HM; Reid DM; Myint PK
Ann Epidemiol; 2018 Aug; 28(8):557-562.e2. PubMed ID: 29937404
[TBL] [Abstract][Full Text] [Related]
31. Fall/Fracture-Related Healthcare Costs and Their Association with Cumulative Anticholinergic Burden in People with Overactive Bladder.
Lozano-Ortega G; Schermer CR; Walker DR; Szabo SM; Rogula B; Deighton AM; Gooch KL; Campbell NL
Pharmacoecon Open; 2021 Mar; 5(1):45-55. PubMed ID: 32291728
[TBL] [Abstract][Full Text] [Related]
32. Anticholinergic burden is associated with recurrent and injurious falls in older individuals.
Zia A; Kamaruzzaman S; Myint PK; Tan MP
Maturitas; 2016 Feb; 84():32-7. PubMed ID: 26531071
[TBL] [Abstract][Full Text] [Related]
33. Are anticholinergic medications used for overactive bladder associated with new onset depression? A population-based matched cohort study.
Welk B; McArthur E
Pharmacoepidemiol Drug Saf; 2020 Dec; 29(12):1710-1714. PubMed ID: 33015899
[TBL] [Abstract][Full Text] [Related]
34. Anticholinergic Prescribing in Medicare Part D Beneficiaries Residing in Nursing Homes: Results from a Retrospective Cross-Sectional Analysis of Medicare Data.
Niznik J; Zhao X; Jiang T; Hanlon JT; Aspinall SL; Thorpe J; Thorpe C
Drugs Aging; 2017 Dec; 34(12):925-939. PubMed ID: 29214512
[TBL] [Abstract][Full Text] [Related]
35. Exposure to anticholinergic and sedative drugs, risk of falls, and mortality: an elderly inpatient, multicenter cohort.
Dauphinot V; Faure R; Omrani S; Goutelle S; Bourguignon L; Krolak-Salmon P; Mouchoux C
J Clin Psychopharmacol; 2014 Oct; 34(5):565-70. PubMed ID: 25133790
[TBL] [Abstract][Full Text] [Related]
36. Anticholinergic medication use and falls in postmenopausal women: findings from the women's health initiative cohort study.
Marcum ZA; Wirtz HS; Pettinger M; LaCroix AZ; Carnahan R; Cauley JA; Bea JW; Gray SL
BMC Geriatr; 2016 Apr; 16():76. PubMed ID: 27038789
[TBL] [Abstract][Full Text] [Related]
37. Health-related consequences of overactive bladder.
Wagner TH; Hu TW; Bentkover J; LeBlanc K; Stewart W; Corey R; Zhou Z; Hunt T
Am J Manag Care; 2002 Dec; 8(19 Suppl):S598-607. PubMed ID: 12516954
[TBL] [Abstract][Full Text] [Related]
38. Cognitive changes in women starting anticholinergic medications for overactive bladder: a prospective study.
Iyer S; Lozo S; Botros C; Wang C; Warren A; Sand P; Tomezsko J; Botros S; Gafni-Kane A; Sasso K; Goldberg RP
Int Urogynecol J; 2020 Dec; 31(12):2653-2660. PubMed ID: 31813036
[TBL] [Abstract][Full Text] [Related]
39. Anticholinergic Burden and Fractures: A Systematic Review with Methodological Appraisal.
Reinold J; Schäfer W; Christianson L; Barone-Adesi F; Riedel O; Pisa FE
Drugs Aging; 2020 Dec; 37(12):885-897. PubMed ID: 33094444
[TBL] [Abstract][Full Text] [Related]
40. Impact of coexisting overactive bladder in Medicare patients with osteoporosis.
Caplan EO; Abbass IM; Suehs BT; Ng DB; Gooch K; Kirby C; Abbott P
Arch Gerontol Geriatr; 2018; 75():44-50. PubMed ID: 29180131
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
